RHOADS ANN D 4

What Happened
Ann D. Rhoads, a director of QuidelOrtho Corporation (QDEL), had 6,829 restricted stock units (RSUs) vest on May 29, 2026. The RSUs were converted into 6,829 shares of common stock (award A and derivative conversion M). No cash was paid on conversion (reported price $0.00).

Key Details

• Transaction date: May 29, 2026 (reported on Form 4 filed June 2, 2026).
• Instruments and amounts: 6,829 RSUs released (footnote F1); 6,829 shares acquired via conversion of derivative (footnote F3).
• Price: $0.00 per share reported (RSUs converted to shares without an exercise price).
• Total cash exchanged: $0 (shares issued on vesting).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnotes: F1 = release of previously reported RSUs; F2 = each RSU equals one share; F3 = RSUs vested on May 29, 2026.
• Timeliness: Form 4 filed June 2, 2026; the filing does not indicate a late-report flag in the provided data.

Context
This was a grant/vesting event (RSU release and conversion to shares), not an open-market purchase or sale. Such vested-share issuances are routine compensation for directors and do not in themselves indicate a buy or sell signal. The derivative code (M) simply reflects conversion/exercise of a derivative award (the RSUs) into ordinary shares.